CMS Coverage Deters Cardiologists From Using Prevention Therapy – Doctors
This article was originally published in The Gray Sheet
Executive Summary
Cardiologists will emphasize cost-effective risk-factor mitigation over device interventions for patients with coronary artery disease if Medicare reimburses intensive diet and lifestyle modification programs, according to a co-investigator in the Medicare Lifestyle Modification Program Demonstration
You may also be interested in...
CMS Expands ICD Coverage In Long-Awaited Decision; Stakeholders Rejoice
CMS' expansion of implantable cardioverter defibrillator Medicare coverage incorporates several recommendations from manufacturers and professional societies
CMS Backs Limited Carotid Stent Coverage Expansion, Mulls Criteria For Docs
CMS is soliciting comments on standards and evaluation criteria for physicians and facilities performing carotid artery stenting procedures (CAS)
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.